Upcoming Events

April 24-26


Join the Rady Children’s Institute of Genomic Medicine for an informative and exciting three days in beautiful La Jolla, California. This year, the first day of the conference will focus on educating the practitioner in the practical use of pediatric genomic medicine. The second day will focus on neuro-developmental pediatric genomics and the third day will include discussions on pediatric genomics in oncology and cardiology, as well as genomics in the newborn period—including the ethical, legal and social implications. Case studies will be used throughout the conference to promote a rich learning experience.

Edico Genome will be sponsoring lunch on the first day of the conference.

Learn More:

April 26-27


Genetic diseases, of which there are over 5000, are the leading cause of death in infants, especially in Neonatal Intensive Care Units (NICU) and Pediatric Intensive Care Units (PICU). Whole genome sequencing and whole exome sequencing are effective methods for diagnosis of genetic diseases. However, they are too slow to have clinical utility in acute care, such as in diagnosis of genetic diseases in very ill infants where there is often a very narrow time window to guide interventions.

Together with the Rady Children’s Institute for Genomic Medicine, we’ve developed an ultra-rapid platform that addresses this issue of time in pediatric genomics. The ultra-rapid platform utilizes DRAGEN, Edico Genome’s bio-IT Platform designed to rapidly accelerate NGS big data analysis by utilizing the efficiency and parallelization that is delivered by implementing Edico Genome’s algorithms on an FPGA-based platform.  This new FPGA-powered infrastructure allows the simultaneous evaluation of nearly all 5,000 known genetic diseases in a single test, enabling NICUs and PICUs like Rady Children’s to diagnose and treat newborns in unprecedented time. Edico Genome and the Rady Children’s Institute for Genomic Medicine recently published a white paper, “Precision Medicine for Newborns by 26-Hour Whole Genome Sequencing,” detailing the ultra-rapid infrastructure and its implementation at Rady Children’s, including findings and results to date.

Register here.


Pieter van Rooyen, Ph.D.

CEO and Founder, Edico Genome

David Dimmock M.D.

Medical Director of Institute for Genomic Medicine, Rady Children’s Hospital – San Diego

May 21


BioData World West 2017

Gavin Stone, VP of Marketing at Edico Genome, will be speaking on the AI track on day 2 at 11:40am. 


The worlds of science and technology have never been so closely intertwined. The potential and applications of bio data are limitless. From patients tracking their own symptoms to doctors virtually assessing patient needs; from personalized sequencing of cancer genomes to defeating aging through AI, it is safe to say the pharma industry will never be the same again.

BioData World West 2017 is bringing scientific innovation to the forefront with tracks on:

1. Genomics
2. Precision Medicine
3. NEW AI track put together in partnership with Merck

Register here.

May 23-25


Bio-IT World Conference & Expo ’17

Edico Genome will be at Booth #222. Along with the Rady Children’s Institute for Genomic Medicine, we are also excited to announce that we have been announced as a finalist for this year’s Bio-IT World Best Practices Awards. You can read about our application project in our recently published white paper: Precision Medicine for Newborns by 26-Hour Whole Genome Sequencing.

Bio-IT World Conference & Expo brings together over 3,300 attendees from 41 countries to navigate the new era of precision medicine and build collaboration across the industry.

With over 13 tracks, 14 pre-conference workshops, and three industry awards, the 2017 Bio-IT World Conference & Expo promises to be bigger than ever with more expert content, more industry insights, and more opportunities to build relationships that will drive the bio-IT industry forward. 

May 28


Diagnosing Genetic Inherited Disorders: Lessons from Leading Women’s and Children’s Hospitals Tickets

Sunday, May 28, 2017 at 7:15 PM

In this Corporate Satellite Seminar, you will hear about the practical advances in genome and exome interpretation from Birmingham Women’s Hospital NHS Foundation Trust (BWCNFT) and Great Ormond Street Hospital (GOSH), two international centres of excellence in healthcare.

Sapientia is a Clinical genome analysis and interpretation platform used to diagnose rare inherited diseases. It is used to support diagnosis at major Children’s Hospitals as well as large-scale National Studies such as the UK 100K Genomes Project.

Speakers Include

  • Dr Dominic McMullan, Consultant Clinical Scientist, WMRGL Birmingham Women’s and Children’s Hospital NHS Foundation Trust
  • Natalie Chandler, Senior Clinical Scientist, Great Ormond Street Hospital for Children NHS Foundation Trust
  • Laura Reed, Pre-Registered Clinical Scientist, Congenica. Laura is a lead scientist working on the UK 100K Genomes Project where she produces Rare Disease Interpretation Reports
  • Gavin Stone, VP Marketing at Edico Genome, provider of DRAGEN Bio-IT Processor, next-generation sequencing bioinformatics chip.

What you will learn

  • Latest technical and scientific advances in genomic-based rare disease interpretation – from a clinical perspective
  • Practical examples from GOSH and Birmingham Women’s and Children’s Hospital
  • Experiences of providing Clinical Interpretation Services for the UK 100K Genomes Project and the Prenatal Assessment of Genomes & Exomes (PAGE) Project

Register here.